NCT03193853 2023-08-07TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast CancerBaylor Research InstitutePhase 2 Completed12 enrolled 11 charts
NCT04073680 2020-05-21A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid TumorsPetra PharmaPhase 1/2 Unknown60 enrolled